• S-Nitrosylation Coordinates Aluminum Resistance

  2026-09-12

  A 2026 Molecular Plant study identifies nitric oxide–dependent S-nitrosylation as a balancing mechanism that differentially controls STOP1 and STAR1 in Arabidopsis. The findings connect STOP1 degradation, STAR1 stabilization, and the coordination of external and internal aluminum detoxification, while also highlighting the importance of preserving protein abundance during downstream analysis.

• EGCG as a Translational Design Lever in Regeneration

  2026-09-11

  (-)-Epigallocatechin gallate (EGCG) is moving beyond the role of a free antioxidant. This thought-leadership analysis examines how its integration into stimulus-responsive biomaterials can connect redox control, apoptosis biology, and translational delivery strategy in intervertebral disc degeneration research.

• VX-702: p38α MAPK Inhibitor Workflows

  2026-09-11

  VX-702 provides a selective, ATP-competitive route to interrogate p38α MAPK signaling across cytokine, platelet, autoimmune, and cardiac injury models. This workflow-focused guide connects biochemical target engagement with translational readouts while emphasizing solvent control, pathway selectivity, and mechanistic troubleshooting.

• ATG4B, Energy Deficiency, and AML DNA Repair

  2026-09-10

  A 2025 Advanced Science study identifies energy deficiency-induced nuclear translocation of ATG4B as a mechanistic link between altered metabolism, defective PRMT1–MRE11 DNA repair, and acute myeloid leukemia progression. Its combination of mechanistic cellular studies, genetically defined leukemia models, and patient-derived xenografts suggests that ATG4B inhibition may reduce genomic instability and improve disease control, while also highlighting important limits to clinical translation.

• Merimepodib (VX-497) Research Workflows

  2026-09-10

  Merimepodib (VX-497) enables controlled interrogation of IMPDH-dependent guanine nucleotide metabolism across antiviral, lymphocyte, and cancer-model assays. This practical workflow connects PEDV findings with dose design, rescue experiments, metabolite readouts, and troubleshooting for more defensible results.

• Bufalin Workflows for STK33 and TNBC Research

  2026-09-09

  Bufalin combines a cardiotonic steroid scaffold with experimentally useful mechanisms for studying apoptosis, protein degradation, and cancer-cell signaling. This guide translates recent STK33 findings into practical TNBC workflows while separating evidence-backed observations from optimization recommendations.

• Zosuquidar (LY335979) in MDR Assays

  2026-09-09

  Learn how Zosuquidar (LY335979) can expose P-glycoprotein-driven resistance in leukemia, lymphoma, solid-tumor, and PROTAC assays. This workflow emphasizes controlled pretreatment, transporter-aware controls, resistance-mechanism mapping, and practical troubleshooting rather than simple endpoint sensitization.

• Uridine, Trisodium Salt for RNA Workflows

  2026-09-08

  Uridine, Trisodium Salt supports controlled RNA metabolism, biochemical synthesis, and exploratory vascular assays without being mistaken for a direct substitute for UTP. This guide connects reagent handling with the RNA-only PRINT platform while separating evidence-based findings from practical laboratory optimization.

• Octenidine Dihydrochloride: Assay Design Guide

  2026-09-08

  Octenidine dihydrochloride is a membrane-active antiseptic research compound whose value depends on more than antimicrobial potency. This guide connects its molecular properties, handling requirements, and assay design to help researchers build reproducible antimicrobial workflows.

• (-)-Epigallocatechin gallate (EGCG) Assay Guide

  2026-09-07

  This scenario-driven guide explains how (-)-Epigallocatechin gallate (EGCG), SKU A2600, can improve the design and interpretation of cell viability, proliferation, and cytotoxicity assays. It covers solvent compatibility, dose and time selection, mechanistic controls, cross-domain limitations, and practical vendor evaluation.

• Pyridostigmine and Placental Necroptosis in PE Models

  2026-09-07

  The reference study identifies placental necroptosis as a modifiable component of preeclampsia-like pathology and links pyridostigmine treatment to α7 nicotinic acetylcholine receptor signaling. Its combination of RUPP rats, human placental observations, α-bungarotoxin blockade, necrostatin-1 comparison, and hypoxic trophoblast assays provides a mechanistic framework for studying cholinergic control of placental inflammation and cell death.

• Pyridostigmine, α7 Signaling, and Placental Necroptosis

  2026-09-05

  A 2026 study links placental ischemia, necroptosis, and impaired non-neuronal cholinergic signaling in a rat model of preeclampsia. Its use of α-bungarotoxin alongside pyridostigmine provides pharmacological evidence that α7 nicotinic acetylcholine receptor signaling contributes to the observed anti-necroptotic and anti-inflammatory effects.

• PNU 74654: Wnt Signaling Pathway Inhibitor

  2026-09-04

  PNU 74654 is a small-molecule Wnt signaling pathway inhibitor supplied for research on Wnt/β-catenin signaling inhibition, cancer biology, and stem cell regulation. Its documented formulation profile supports DMSO-based workflows, while peer-reviewed evidence establishes pathway relevance but does not by itself validate PNU 74654 in every biological model.

• Annexin V-FITC/PI Apoptosis Assay Kit Workflow

  2026-09-04

  Resolve viable, early apoptotic, late apoptotic, and membrane-compromised cells in a rapid two-parameter workflow. This practical guide applies the assay to hypoxia-activated cancer therapies, including the BNNC photomolecular glue strategy, while emphasizing controls, gating, and troubleshooting.

• QNZ (EVP4593): NF-κB Research Workflows

  2026-09-03

  QNZ (EVP4593) gives researchers a nanomolar tool for connecting NF-κB reporter output with TNF-α and calcium phenotypes, from Jurkat inflammation assays to YAC128 Huntington’s disease models. This workflow emphasizes solvent control, orthogonal readouts, and careful separation of infection surveillance from mechanistic claims.

8498 records 1/567 page Next 12345 下5页 Last page